NEOG Stock Overview
Engages in the development, manufacture, and marketing of various products and services dedicated to food and animal safety worldwide.
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 3/6 |
Past Performance | 1/6 |
Financial Health | 2/6 |
Dividends | 0/6 |
Neogen Corporation Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$13.15 |
52 Week High | US$24.10 |
52 Week Low | US$11.46 |
Beta | 1.17 |
1 Month Change | 9.40% |
3 Month Change | -21.54% |
1 Year Change | -28.53% |
3 Year Change | -71.20% |
5 Year Change | -55.08% |
Change since IPO | 5,045.56% |
Recent News & Updates
There's Reason For Concern Over Neogen Corporation's (NASDAQ:NEOG) Price
May 21Battered By M&A Integration Issues, Neogen Has To Rebuild Investor Trust
Apr 15Neogen Corporation Just Reported A Surprise Loss: Here's What Analysts Think Will Happen Next
Apr 12Recent updates
There's Reason For Concern Over Neogen Corporation's (NASDAQ:NEOG) Price
May 21Battered By M&A Integration Issues, Neogen Has To Rebuild Investor Trust
Apr 15Neogen Corporation Just Reported A Surprise Loss: Here's What Analysts Think Will Happen Next
Apr 12Neogen (NASDAQ:NEOG) Takes On Some Risk With Its Use Of Debt
Mar 29Neogen: All About Execution From Here On
Mar 26Statutory Profit Doesn't Reflect How Good Neogen's (NASDAQ:NEOG) Earnings Are
Jan 17Neogen Corporation Just Missed Earnings With A Surprise Loss - Here Are Analysts Latest Forecasts
Jan 12Neogen Corporation (NASDAQ:NEOG) Investors Are Less Pessimistic Than Expected
Jan 09Here's Why Neogen (NASDAQ:NEOG) Can Manage Its Debt Responsibly
Dec 06Neogen (NASDAQ:NEOG) Has A Somewhat Strained Balance Sheet
Jul 12Is There An Opportunity With Neogen Corporation's (NASDAQ:NEOG) 46% Undervaluation?
Jun 20Neogen (NASDAQ:NEOG) Has A Somewhat Strained Balance Sheet
Mar 25Neogen introduces ready-to-use disinfectant Companion RTU for veterinary use
Oct 10Neogen GAAP EPS of $0.05, revenue of $132.35M
Sep 27Neogen drops 9% as merger with 3M’s food safety business closes
Sep 01Broker Revenue Forecasts For Neogen Corporation (NASDAQ:NEOG) Are Surging Higher
Aug 21Neogen: Cut In Half, Still Some Questions
Aug 12There May Be Reason For Hope In Neogen's (NASDAQ:NEOG) Disappointing Earnings
Aug 04Neogen: Thesis Unchanged After Q4 And Full-Year Earnings
Aug 01Neogen FQ4 2022 Earnings Preview
Jul 25Zoetis, IDEXX named as buys in animal health space by Piper Sandler
Jul 13Neogen announces pricing of $350M senior notes offering
Jul 07Neogen: Safety Food Giant In The Making
Dec 15Neogen (NASDAQ:NEOG) Will Want To Turn Around Its Return Trends
Dec 12Neogen (NASDAQ:NEOG) Will Want To Turn Around Its Return Trends
Sep 12Robust Valuation Leaves Neogen Little Room For Error After Mixed Results
Jul 27Shareholder Returns
NEOG | US Medical Equipment | US Market | |
---|---|---|---|
7D | -0.8% | -0.8% | -0.6% |
1Y | -28.5% | 1.9% | 22.5% |
Return vs Industry: NEOG underperformed the US Medical Equipment industry which returned 1.9% over the past year.
Return vs Market: NEOG underperformed the US Market which returned 22.5% over the past year.
Price Volatility
NEOG volatility | |
---|---|
NEOG Average Weekly Movement | 5.5% |
Medical Equipment Industry Average Movement | 7.8% |
Market Average Movement | 5.8% |
10% most volatile stocks in US Market | 15.7% |
10% least volatile stocks in US Market | 2.9% |
Stable Share Price: NEOG's share price has been volatile over the past 3 months.
Volatility Over Time: NEOG's weekly volatility (6%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1981 | 2,640 | John Adent | www.neogen.com |
Neogen Corporation, together with its subsidiaries, engages in the development, manufacture, and marketing of various products and services dedicated to food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test to detect the presence of adenosine triphosphate, a chemical found in living cells, as well as provides genomics-based diagnostic technology and software systems that help testers to objectively analyze and store their results and perform analysis on the results from multiple locations over extended periods.
Neogen Corporation Fundamentals Summary
NEOG fundamental statistics | |
---|---|
Market cap | US$2.85b |
Earnings (TTM) | US$1.57m |
Revenue (TTM) | US$929.24m |
1,819x
P/E Ratio3.1x
P/S RatioIs NEOG overvalued?
See Fair Value and valuation analysisEarnings & Revenue
NEOG income statement (TTM) | |
---|---|
Revenue | US$929.24m |
Cost of Revenue | US$452.39m |
Gross Profit | US$476.85m |
Other Expenses | US$475.28m |
Earnings | US$1.57m |
Last Reported Earnings
Feb 29, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 0.0072 |
Gross Margin | 51.32% |
Net Profit Margin | 0.17% |
Debt/Equity Ratio | 28.3% |
How did NEOG perform over the long term?
See historical performance and comparison